SCHEMBL2560090

SCHEMBL2560090

CC(NCC(=O)O)C(N)=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.40
LMNA P02545 1/20 0.40
MAPT P10636 1/20 0.40
PTGS2 P35354 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
ECE1 P42892 1/20 0.35
GABRP O00591 2/20 0.34
GABRD O14764 2/20 0.34
GABRA1 P14867 2/20 0.34
GABRB1 P18505 2/20 0.34
GABRG2 P18507 2/20 0.34
GABRB3 P28472 2/20 0.34
GABRA5 P31644 2/20 0.34
GABRA3 P34903 2/20 0.34
GABRA2 P47869 2/20 0.34
GABRB2 P47870 2/20 0.34
GABRA4 P48169 2/20 0.34
GABRE P78334 2/20 0.34
GABRA6 Q16445 2/20 0.34
GABRG1 Q8N1C3 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7319087 0.98 ALDH1A1 (0.39) ALDH1A1LMNAMAPTPTGS2TDP1
SCHEMBL12226425 0.81 ALDH1A1 (0.35) ALDH1A1LMNATDP1GABRPGABRD
SCHEMBL1700840 0.80 ALDH1A1 (0.43) ALDH1A1LMNAMAPTPTGS2TDP1
SCHEMBL2805307 0.80 ALDH1A1 (0.43) ALDH1A1LMNAMAPTPTGS2TDP1
SCHEMBL2132525 0.80 ALDH1A1 (0.43) ALDH1A1LMNAMAPTPTGS2TDP1
SCHEMBL7429510 0.79 CA14 (0.45) ALDH1A1LMNAMAPTPTGS2TDP1
SCHEMBL7432682 0.79 CA14 (0.45) ALDH1A1LMNAMAPTPTGS2TDP1
SCHEMBL667846 0.78 ALDH1A1 (0.41) ALDH1A1LMNAMAPTPTGS2TDP1
SCHEMBL14056387 0.78 ALDH1A1 (0.41) ALDH1A1LMNAMAPTPTGS2TDP1
Hydrochloric Acid SCHEMBL10578120 0.78 ALDH1A1 (0.41) ALDH1A1LMNAMAPTPTGS2TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220340893-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2022-10-27 US disclosed
US-11225655-B2 Bi-functional complexes and methods for making and using such complexes NUEVOLUTION A/S (DK) 2022-01-18 US disclosed
US-20200188476-A1 ANTI-MICROBIAL AGENT-POLYMER CONJUGATES AND METHODS OF USE THEREOF UNIV CALIFORNIA (US) 2020-06-18 US disclosed
EP-3540059-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES Nuevolution A/S (DK) 2019-09-18 EP disclosed
EP-2558577-B1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION AS (DK) 2018-12-12 EP disclosed
WO-2018195078-A1 ANTI-MICROBIAL AGENT-POLYMER CONJUGATES AND METHODS OF USE THEREOF THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2018-10-25 WO disclosed
CN-104086633-B Short fatty acid tail polymyxin derivatives and application thereof 北方抗生素有限公司 2018-02-09 CN disclosed
EP-3263586-A1 SHORT FATTY ACID TAIL POLYMYXIN DERIVATIVES AND USES THEREOF Northern Antibiotics Oy (FI) 2018-01-03 EP disclosed
EP-3078672-A1 POLYMYXIN DERIVATIVES AND USES THEREOF Northern Antibiotics Oy (FI) 2016-10-12 EP disclosed
EP-2057185-B1 POLYMYXIN DERIVATIVES AND USES THEREOF NORTHERN ANTIBIOTICS OY (FI) 2016-05-11 EP disclosed
US-7807637-B2 Polymyxin derivatives and uses thereof NORTHERN ANTIBIOTICS OY (FI) 2010-10-05 US disclosed
US-20090239792-A1 SHORT FATTY ACID TAIL POLYMYXIN DERIVATIVES AND USES THEREOF NORTHERN ANTIBIOTICS LTD. (FI) 2009-09-24 US disclosed
US-20090215677-A1 POLYMYXIN DERIVATIVES AND USES THEREOF NORTHERN ANTIBIOTICS LTD. (FI) 2009-08-27 US disclosed
WO-2009098357-A1 SHORT FATTY ACID TAIL POLYMYXIN DERIVATIVES AND USES THEREOF NORTHERN ANTIBIOTICS OY (FI) 2009-08-13 WO disclosed
CN-101501063-A Polymyxin derivatives and uses thereof NORTHERN ANTIBIOTICS OY (FI) 2009-08-05 CN disclosed
CN-101500591-A Composition for detecting virus and method for detecting virus using the same MND DIAGNOSTIC LTD (IL) 2009-08-05 CN disclosed
EP-2057185-A1 POLYMYXIN DERIVATIVES AND USES THEREOF Northern Antibiotics Oy (FI) 2009-05-13 EP disclosed
US-20080287345-A1 Polymyxin derivatives and uses thereof NORTHERN ANTIBIOTICS OY (FI) 2008-11-20 US disclosed
WO-2008017734-A1 POLYMYXIN DERIVATIVES AND USES THEREOF NORTHERN ANTIBIOTICS OY (FI) 2008-02-14 WO disclosed
CN-1351663-A Viral variants NORTH WESTER HEALTH CARE NETWO (AU) 2002-05-29 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090239792-A1 SHORT FATTY ACID TAIL POLYMYXIN DERIVATIVES AND USES THEREOF TLR5, TLR3, TLR2 ALDH1A1 4688/4885LMNA 1825/4885MAPT 4879/4885
US-20090215677-A1 POLYMYXIN DERIVATIVES AND USES THEREOF C5, C9, C3AR1 ALDH1A1 4876/4885LMNA 3052/4885MAPT 4881/4885
US-20200188476-A1 ANTI-MICROBIAL AGENT-POLYMER CONJUGATES AND METHODS OF USE THEREOF DDOST, MGAM, MSN ALDH1A1 4571/4885LMNA 4287/4885MAPT 2969/4885
US-20080287345-A1 Polymyxin derivatives and uses thereof C9, C5, C3AR1 ALDH1A1 4876/4885LMNA 3194/4885MAPT 4879/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.